Physician profile
Kerry Luck
NPI 1265484497
$442.70
in general payments reported to CMS, 2019-2025
7 companies · $93.93 in 2025
The $93.93 reported for 2025 was more than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $65.45 · 2020: $29.16 · 2021: $83.61 · 2022: $19.35 · 2023: $124 · 2024: $27.16 · 2025: $93.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $245.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $245.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $108.16 | 2023 | Dupixent |
| Acelrx Pharmaceuticals, INC. | $104.49 | 2019-2021 | |
| Janssen Biotech, INC. | $90.28 | 2024-2025 | Tremfya |
| Merck Sharp & Dohme LLC | $68.25 | 2019-2025 | Bridion |
| Cumberland Pharmaceuticals, INC. | $41.57 | 2019-2021 | |
| Ironwood Pharmaceuticals, INC | $15.88 | 2023 | Linzess |
| Takeda Pharmaceuticals U.S.A., INC. | $14.07 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kerry Luck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.